SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001137892-08-000017
Filing Date
2008-04-18
Accepted
2008-04-18 14:40:11
Documents
1
Period of Report
2005-10-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 7482
  Complete submission text file 0001137892-08-000017.txt   9308
Mailing Address 101 EAST GREEN ST STE 11 PASADENA CA 91105
Business Address 101 EAST GREEN ST #11 PASADENA CA 91105 8184050079
SANGUINE CORP (Issuer) CIK: 0000926287 (see all company filings)

IRS No.: 954347608 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 455 EAST 500 SOUTH, SUITE 201 SALT LAKE CITY UT 84111
Business Address 801-532-1742
Nelson David E (Reporting) CIK: 0001305742 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-24480 | Film No.: 08764374